Correlation Between Gilead Sciences and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Spero Therapeutics, you can compare the effects of market volatilities on Gilead Sciences and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Spero Therapeutics.
Diversification Opportunities for Gilead Sciences and Spero Therapeutics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gilead and Spero is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Gilead Sciences and Spero Therapeutics
Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.68 times more return on investment than Spero Therapeutics. However, Gilead Sciences is 1.47 times less risky than Spero Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 8,951 in Gilead Sciences on September 2, 2024 and sell it today you would earn a total of 307.00 from holding Gilead Sciences or generate 3.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Spero Therapeutics
Performance |
| Timeline |
| Gilead Sciences |
| Spero Therapeutics |
Gilead Sciences and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Spero Therapeutics
The main advantage of trading using opposite Gilead Sciences and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |